Boule Diagnostics AB will publish the year-end report for 2025 at 08:00, Wednesday, February 11, 2026. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Torben Nielsen and CFO Holger Lembrér will present and comment on the report. After the presentation there will be time for audience questions. The presentation will be held in English.
The interim report will be accessible atwww.boule.comwhen published.
Enter the Teams live event and download presentation material at:https://boule.com/investor-relations/
Contacts
Torben Nielsen, CEO and Group President,, phone +46 (0)70-558 51 05
Holger Lembrér, CFO,, phone +46 (0)72-230 77 10
About Us
Boule Diagnostics AB (publ) is a global company consisting of two business segments, Diagnostics and OEM CDS. Diagnostics is specialized in near-patient, decentralized diagnostic solutions for human and veterinary applications, serving hospitals, clinics, laboratories. OEM CDS develops and delivers reliable reagent, blood controls and calibrators tailored for diagnostic companies worldwide.
With operations in Sweden, the United States, Mexico, and Russia, and a global distribution network spanning more than 100 countries, Boule combines a resilient business model with strong positions in key growth markets. In 2024, Boule reported net sales of SEK 558 million and has about 200 employees worldwide. Boule has been listed on Nasdaq Stockholm since 2011.http://www.boule.com
Attachments